Reconstitution of caspase-mediated cell-death signalling in Schizosaccharomyces pombe

被引:22
|
作者
Ryser, S
Vial, E
Magnenat, E
Schlegel, W
Maundrell, K
机构
[1] Fdn Rech Med, CH-1211 Geneva 4, Switzerland
[2] Ares Serono, CH-1211 Geneva, Switzerland
关键词
fission yeast; caspases; Bcl-2; apoptosis;
D O I
10.1007/s002940050468
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Two pro-apoptotic proteases, caspase-1 and caspase-3, have been expressed as full-length proteins in the fission yeast Schizosaccharomyces pombe. Both proteins autoprocess to generate the corresponding active enzyme and both are lethal to the yeast cell. Lethality is due to catalytic activity since the expression of the inactive mutant forms of both caspases does not result in an obvious phenotype. Caspase-expressing yeast can be rescued by co-expression of the baculovirus protein p35, a known inhibitor of the caspase family. Go-expression of Bcl-2, another anti-apoptotic protein, does not prevent the cell death induced by either caspase. However, Bcl-2 is itself cleaved by both caspase-1 and caspase-3 at two adjacent recognition sites, YEWD(31)A and DAGD(34)V respectively, immediately downstream from the N-terminal BH4 domain, a region of Bcl-2 which is essential for its anti-apoptotic activity; similar cleavage of Bcl-2 by caspases has been demonstrated in mammalian cells. Hence, key elements of the apoptotic pathway can be reliably reconstituted in fission yeast, opening the way to exploit yeast in order to study the control of apoptosis. Furthermore, the activity of caspase-3, although not caspase-1, can be demonstrated in vitro using chromogenic substrates. This offers the possibility of using caspase-producing strains of yeast to screen for chemical inhibitors either in vivo or in vitro.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [1] Reconstitution of caspase-mediated cell-death signalling in Schizosaccharomyces pombe
    Stephan Ryser
    Elisabeth Vial
    Edith Magnenat
    Werner Schlegel
    Kinsey Maundrell
    Current Genetics, 1999, 36 : 21 - 28
  • [2] Caspase-mediated cell death in cerebral ischemia
    Moskowitz, MA
    Dalkara, T
    PHARMACOLOGY OF CEREBRAL ISCHEMIA 1998, 1999, : 269 - 275
  • [3] Caspase-mediated parkin cleavage in apoptotic cell death
    Kahns, S
    Lykkobo, S
    Jakobsen, LD
    Nielsen, MS
    Jensen, PH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) : 15303 - 15308
  • [4] Alterations in mitochondrial morphology of Schizosaccharomyces pombe induced by cell-death promoting agents
    Pevala, V.
    Kolarov, J.
    Polcic, P.
    FOLIA MICROBIOLOGICA, 2007, 52 (04) : 381 - 390
  • [5] Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination
    Hisahara, S
    Okano, H
    Miura, M
    NEUROSCIENCE RESEARCH, 2003, 46 (04) : 387 - 397
  • [6] Evolution of caspase-mediated cell death and differentiation: twins separated at birth
    Ryan A V Bell
    Lynn A Megeney
    Cell Death & Differentiation, 2017, 24 : 1359 - 1368
  • [7] Oxyhemoglobin induces caspase-mediated cell death in cerebral endothelial cells
    Meguro, T
    Chen, B
    Lancon, J
    Zhang, JH
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 (04) : 1128 - 1135
  • [8] Evolution of caspase-mediated cell death and differentiation: twins separated at birth
    Bell, Ryan A. V.
    Megeney, Lynn A.
    CELL DEATH AND DIFFERENTIATION, 2017, 24 (08): : 1359 - 1368
  • [9] Hypoxia, hypoglycemia, and caspase-mediated cell death in the mature and premature ductus arteriosus
    Goldbarg, S
    Quinn, T
    Waleh, N
    Clyman, R
    PEDIATRIC RESEARCH, 2002, 51 (04) : 36A - 37A
  • [10] Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer
    Wen, X.
    Lin, Z. -Q.
    Liu, B.
    Wei, Y. -Q.
    CELL PROLIFERATION, 2012, 45 (03) : 217 - 224